MedPath
HSA Approval

CAVINTON TABLET 5 mg

SIN00396P

CAVINTON TABLET 5 mg

CAVINTON TABLET 5 mg

April 26, 1988

PHARMLINE MARKETING PTE. LTD.

PHARMLINE MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMLINE MARKETING PTE. LTD.
Licence HolderPHARMLINE MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

N06BX18

vinpocetine

Manufacturer Information

PHARMLINE MARKETING PTE. LTD.

CHEMICAL WORKS OF GEDEON RICHTER PLC

Active Ingredients

VINPOCETINE

5 mg

Vinpocetine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CAVINTON TABLET 5 mg - HSA Approval | MedPath